TSX:AIDX - Toronto Stock Exchange - CA42249X1006 - Common Stock - Currency: CAD
TSX:AIDX (6/4/2025, 7:00:00 PM)
1.35
-0.01 (-0.74%)
The current stock price of AIDX.CA is 1.35 CAD. In the past month the price decreased by -4.26%. In the past year, price decreased by -41.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 24.67B | ||
AND.CA | ANDLAUER HEALTHCARE GROUP IN | 33.34 | 2.09B | ||
DNTL.CA | DENTALCORP HOLDINGS LTD | 22.31 | 1.65B | ||
WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 1.00B | ||
QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 121.59M | ||
NLH.CA | NOVA LEAP HEALTH CORP | 26.5 | 23.14M | ||
NPTH.CA | NEUPATH HEALTH INC | N/A | 14.74M | ||
ARC.CA | ARCPOINT INC | 4 | 10.27M | ||
PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 3.61M | ||
JNH.CA | JACK NATHAN MEDICAL CORP | N/A | 871.00K |
HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere divisions. The firm's AutoScribe platform is an advanced AI-powered ambient scribe solution. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.
HEALWELL AI INC
4881 Yonge Street, Suite 300
TORONTO ONTARIO CA
Employees: 102
The current stock price of AIDX.CA is 1.35 CAD. The price decreased by -0.74% in the last trading session.
The exchange symbol of HEALWELL AI INC is AIDX and it is listed on the Toronto Stock Exchange exchange.
AIDX.CA stock is listed on the Toronto Stock Exchange exchange.
16 analysts have analysed AIDX.CA and the average price target is 3.62 CAD. This implies a price increase of 167.84% is expected in the next year compared to the current price of 1.35. Check the HEALWELL AI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HEALWELL AI INC (AIDX.CA) has a market capitalization of 357.52M CAD. This makes AIDX.CA a Small Cap stock.
HEALWELL AI INC (AIDX.CA) currently has 102 employees.
HEALWELL AI INC (AIDX.CA) has a support level at 1.33 and a resistance level at 1.37. Check the full technical report for a detailed analysis of AIDX.CA support and resistance levels.
The Revenue of HEALWELL AI INC (AIDX.CA) is expected to grow by 255.42% in the next year. Check the estimates tab for more information on the AIDX.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AIDX.CA does not pay a dividend.
HEALWELL AI INC (AIDX.CA) will report earnings on 2025-08-11.
HEALWELL AI INC (AIDX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
ChartMill assigns a fundamental rating of 3 / 10 to AIDX.CA. The financial health of AIDX.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months AIDX.CA reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 62.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -31.28% | ||
ROE | -55.67% | ||
Debt/Equity | 0.17 |
ChartMill assigns a Buy % Consensus number of 83% to AIDX.CA. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 71.31% and a revenue growth 255.42% for AIDX.CA